<html><body><table><thead><tr class="rowsep-1 valign-bottom"><th rowspan="2" scope="col"><strong>ID</strong></th><th rowspan="2" scope="col"><strong>Sex</strong></th><th rowspan="2" scope="col"><strong>Age at Last Visit</strong></th><th scope="col"><strong><em>IARS</em> Mutations</strong></th><th rowspan="2" scope="col"><strong>AO</strong></th><th colspan="4" scope="col"><strong>Clinical Features</strong></th></tr><tr class="rowsep-1 valign-bottom"><th scope="col"><strong>cDNA (NM_002161.5); protein (EAW62813.1)</strong></th><th scope="col"><strong> <span style="color:red" title="HPO: HP:0001510
CONF: 1" >Growth Retardation</span>  (SDS)</strong><a class="workspace-trigger" href="#tblfn1" name="btblfn1"><strong><sup>a</sup></strong></a></th><th scope="col"><strong>Neurological and Cognitive Outcome</strong></th><th scope="col"><strong>Liver Function (Histologic Findings)</strong></th><th scope="col"><strong>Other Features</strong></th></tr></thead><tbody><tr class="valign-top"><td>#65269 (DEU)</td><td>M</td><td>18.7 years</td><td>c. [1252C&gt;T];[3521T&gt;A]; p.[Arg418<sup>∗</sup>];[Ile1174Asn]</td><td>prenatal (IUGR)</td><td>yes (−5.9)</td><td>moderate to  <span style="color:red" title="HPO: HP:0010864
CONF: 1" >severe intellectual disability</span> , no expressive speech,  <span style="color:red" title="HPO: HP:0001257
CONF: 1" >spastic</span>   <span style="color:red" title="HPO: HP:0100022
CONF: 1" >movement disorder</span>  (GMFCS IV), <span style="color:red" title="HPO: HP:0001252
CONF: 1" > muscular hypotoni</span> a, brain MRI abnormal</td><td>intermittently mildly <span style="color:red" title="HPO: HP:0032320
CONF: 1" > affecte</span> d hepatic synthesis (no liver biopsy)</td><td <span style="color:red" title="HPO: HP:0000486
CONF: 1" >>strabismu</span> s, feeding through PEG, <span style="color:red" title="HPO: HP:0100633
CONF: 1" > esophagiti</span> s, zinc deficiency (8.5 μmol/L; N 13–18)<a class="workspace-trigger" href="#tblfn2" name="btblfn2"><sup>b</sup></a></td></tr><tr class="valign-top"><td>#85880 (JPN)</td><td>F</td><td>19 years</td><td>c. [760C&gt;T];[1310C&gt;T]; p.[Arg254<sup>∗</sup>];[Pro437Leu]</td><td>prenatal (IUGR)</td><td>yes (−6.2)</td><td> <span style="color:red" title="HPO: HP:0002342
CONF: 1" >moderate intellectual disability</span>  (IQ 50), motor function normal</td><td>elevated ALAT and ASAT, neonatal onset ( <span style="color:red" title="HPO: HP:0001397
CONF: 1" >steatosis</span> , fibrosis)</td><td>sensoneurinal  <span style="color:red" title="HPO: HP:0000365
CONF: 1" >hearing loss</span>  (AO 5 years),  <span style="color:red" title="HPO: HP:0000819
CONF: 1" >diabetes mellitus</span>  (AO 16 years),  <span style="color:red" title="HPO: HP:0001250
CONF: 1" >epilepsy</span> , zinc deficiency (7.5 μmol/L; N 11–18)<a class="workspace-trigger" href="#tblfn2" name="btblfn2"><sup>b</sup></a></td></tr><tr class="valign-top"><td>#83921 (AUT)</td><td>M</td><td>3 years</td><td>c. [1109T&gt;G];[2974A&gt;G]; p.[Val370Gly];[Asn992Asp]</td><td>prenatal (IUGR)</td><td>yes (−6.2)</td><td>moderate intellectual and motor disability, muscular hypotonia</td><td>recurrent liver crises triggered by infections, infantile  <span style="color:red" title="HPO: HP:0001399
CONF: 1" >liver failure</span> , neonatal onset ( <span style="color:red" title="HPO: HP:0001397
CONF: 1" >steatosis</span> , fibrosis, cholestasis)</td><td>peculiar facial distribution of subcutaneous fat (chubby cheeks), feeding through PEG, zinc deficiency (6.1 μmol/L; N 11–15)<a class="workspace-trigger" href="#tblfn2" name="btblfn2"><sup>b</sup></a></td></tr></tbody></table></body></html>